Inamrinone
Click to View Image
C10H9N3O 187.20

[3,4¢-Bipyridin]-6(1H)-one,5-amino-.
5-Amino[3,4¢-bipyridin]-6(1H)-one [60719-84-8].
»Inamrinone contains not less than 98.0percent and not more than 102.0percent of C10H9N3O,calculated on the anhydrous basis.
Caution—Inamrinone is a cardiotonic agent.
Packaging and storage— Preserve in well-closed containers,protected from light.Store at 25,excursions permitted between 15and 30.
Identification—
A:Infrared Absorption á197Kñ.
B:Ultraviolet Absorption á197Uñ
pH8.9Buffer— Dissolve 107g of dibasic sodium phosphate in water,adjust,if necessary,with 0.1Msodium hydroxide or 0.1Mphosphoric acid to a pHof 8.9±0.1,dilute with water to 1000mL,and mix.
Solution: 6µg per mL,prepared as follows.Dissolve 100mg in 20mLof water and 1.0mLof 1Nhydrochloric acid in a 100-mLvolumetric flask,dilute with water to volume,and mix.Dilute 5.0mLof this solution to 50.0mLwith 0.01Nhydrochloric acid,mix,and transfer 3.0mLto a 50-mLvolumetric flask.Dilute with pH8.9Bufferto volume,and mix.
Ratio: A237/A318do not differ by more than 3.0%.
Water,Method Iá921ñ: not more than 1.0%.
Residue on ignition á281ñ: not more than 0.2%.
Chromatographic purity—
Solution A— Dissolve 6.8g of monobasic potassium phosphate in 1000mLof water,add 2mLof triethylamine,and adjust with phosphoric acid to a pHof 2.5.Filter and degas.Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Solution B— Prepare a mixture of Solution Aand acetonitrile (85:15).
Mobile phase— Use variable mixtures of Solution Aand Solution Bas directed for Chromatographic system.
Diluting solution— Dissolve 0.25g of sodium metabisulfite in 1000mLof Mobile phase A.
Standard stock solution— Dissolve an accurately weighed quantity of USP Inamrinone RSin Diluting solutionto obtain a solution having a known concentration of about 2mg per mL.
Standard solution— Dilute a suitable volume of Standard stock solutionquantitatively,and stepwise if necessary,with Diluting solutionto obtain a solution having a known concentration of 4µg of USP Inamrinone RSper mL.
System suitability solution— Prepare a solution of USP Inamrinone Related Compound A RSin Diluting solutionhaving a concentration of 2mg per mL.Transfer 5.0mLof this solution and 5.0mLof the Standard stock solutionto a 50-mLvolumetric flask,dilute with Diluting solutionto volume,and mix.
Test solution— Transfer about 100mg of Inamrinone,accurately weighed,to a 50-mLvolumetric flask,dissolve in and dilute with Diluting solutionto volume,and mix.[NOTE—Use this solution within 1hour after preparation.]
Chromatographic system(see Chromatography á621ñ)— The liquid chromatograph is equipped with a 315-nm detector and a 4.0-mm ×25-cm analytical column that contains packing L1and is fitted with a guard column that contains packing L1.The flow rate is about 1.0mLper minute.The chromatograph is programmed as follows.
Time
(minutes)
Solution A
(%)
Solution B
(%)
Elution
0 87 13 equilibration
0–1 87 13 isocratic
1–29 87®0 13®100 linear gradient
29–30 0 100 isocratic
Allow the system to equilibrate at the original conditions before making subsequent injections.Chromatograph 15µLof the System suitability solution,record the chromatograms,and measure the peak responses as described for Procedure:the relative retention times are 0.6for inamrinone and 1.0for inamrinone related compound A;and the resolution,R,between inamrinone and inamrinone related compound Ais not less than 4.0.Chromatograph about 15µLof the Standard solution,and record the peak responses for inamrinone as directed for Procedure:the relative standard deviation for replicate injections is not more than 5.0%.
Procedure— Separately inject equal volumes (about 15µL)of the Standard solutionand the Test solutioninto the chromatograph,record the chromatograms allowing the Test solutionto elute for not less than five times the retention times of inamrinone,and measure the areas of all the peaks observed in the chromatogram of the Test solution.Calculate the percentage of each impurity in the portion of Inamrinone taken by the formula:
5000(C/W)(ri/rS),
in which Cis the concentration,in mg per mL,of USP Inamrinone RSin the Standard solution;Wis the weight,in mg,of inamrinone taken for the Test solution;riis the response of each impurity peak;and rSis the mean response for the Standard solution:not more than 0.2%of any individual impurity is found;and the sum of all impurities is not more than 1.0%.
Assay— Weigh accurately about 500mg of Inamrinone,and proceed as directed under Nitrite Titration á451ñ.Each mLof 0.1Msodium nitrite is equivalent to 18.72mg of C10H9N3O.
Auxiliary Information— Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28–NF23Page 1004
Pharmacopeial Forum:Volume No.29(5)Page 1507
Phone Number:1-301-816-8305